Table 4.
Mediator (pg/ml) | Post LPS challenge Day 3 saline nare | Post LPS Challenge Day 3 LPS nare |
---|---|---|
IL-8 | 1458 (327)* | 798 (137)* |
sCD14 | 8503 (1598)# | 5067 (911)# |
IL-6 | 194 (96) | 112 (38) |
IL-1β | 98 (46) | 53 (19) |
GM-CSF | 302 (59), n = 9 | 323 (44), n = 10 |
ECP | 23 (7), n = 7 | 17 (11), n = 7 |
Significant decrease in IL-8 in nare with repeat LPS challenges as opposed to the nare that received saline on two prior days (p = 0.03).
Trending toward significant decrease in sCD14 in nare with repeat LPS challenges as opposed to the nare that received saline on two prior days (p = 0.06).